Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1983-7-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0160-6689
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6853455-Ambulatory Care,
pubmed-meshheading:6853455-Amitriptyline,
pubmed-meshheading:6853455-Depressive Disorder,
pubmed-meshheading:6853455-Doxepin,
pubmed-meshheading:6853455-Drug Combinations,
pubmed-meshheading:6853455-Drug Therapy, Combination,
pubmed-meshheading:6853455-Humans,
pubmed-meshheading:6853455-Perphenazine
|
pubmed:year |
1983
|
pubmed:articleTitle |
Is amitriptyline + perphenazine superior to doxepin?
|
pubmed:publicationType |
Letter,
Comparative Study
|